Inventor
MENENDEZ ELIZABETH-EDNA MARY
US12 patents
Patents
12 patentsUS9127053B2Sep 8, 2015
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC39 citations97
US9120853B2Sep 1, 2015
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC52 citations97
US10301380B2May 28, 2019
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC17 citations94
US9889211B2Feb 13, 2018
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC29 citations94
US9545442B2Jan 17, 2017
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC19 citations92
US10261083B2Apr 16, 2019
Compositions and methods for detecting protease activity in biological systems
CYTOMX THERAPEUTICS INC14 citations85
US10709799B2Jul 14, 2020
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC10 citations84
US9688748B2Jun 27, 2017
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC11 citations84
US11890354B2Feb 6, 2024
Activatable antibodies that bind epidermal growth factor receptor and methods thereof
CYTOMX THERAPEUTICS INC2 citations73
US11867695B2Jan 9, 2024
Compositions and methods for detecting protease activity in biological systems
CYTOMX THERAPEUTICS INC2 citations72
US11035859B2Jun 15, 2021
Compositions and methods for detecting protease activity in biological systems
CYTOMX THERAPEUTICS INC3 citations72
US12502439B2Dec 23, 2025
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62